1. Home
  2. TRIB vs SNTI Comparison

TRIB vs SNTI Comparison

Compare TRIB & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRIB

Trinity Biotech plc

HOLD

Current Price

$1.06

Market Cap

18.3M

Sector

Health Care

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.33

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRIB
SNTI
Founded
1992
2016
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
53.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TRIB
SNTI
Price
$1.06
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
83.5K
4.1M
Earning Date
03-23-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,555,000.00
N/A
Revenue This Year
$13.51
N/A
Revenue Next Year
$13.14
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
8.31
N/A
52 Week Low
$0.48
$1.26
52 Week High
$3.44
$5.96

Technical Indicators

Market Signals
Indicator
TRIB
SNTI
Relative Strength Index (RSI) 56.07 34.89
Support Level $1.04 $1.34
Resistance Level $1.22 $2.88
Average True Range (ATR) 0.09 0.25
MACD 0.02 -0.09
Stochastic Oscillator 59.97 2.48

Price Performance

Historical Comparison
TRIB
SNTI

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: